PEDIATRICS Vol. 93 No. 6 June 1994, pp. 996-999
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watchko, J. F.
Right arrow Articles by Claassen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watchko, J. F.
Right arrow Articles by Claassen, D.

Kernicterus in Premature Infants: Current Prevalence and Relationship to NICHD Phototherapy Study Exchange Criteria

Jon F. Watchko MD1 and Diana Claassen MD2

1 Department of Pediatrics, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA
2 Department of Pathology, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA

Objective. This study was undertaken to determine the current prevalence of kernicterus in premature neonates and to relate the occurrence of kernicterus to 1) the categorization of the infant as "at risk" by National Institute of Child Health and Human Development (NICHD) Phototherapy Study exchange transfusion criteria, and 2) the clinical management of the infant's hyperbilirubinemia.

Design. Retrospective review of postmortem and clinical records.

Setting. Magee-Womens Hospital, a University of Pittsburgh Medical Center affiliated hospital with approximately 10 000 deliveries per year and a Level III Neonatal Intensive Care Unit with about 1400 admissions annually.

Subjects. All neonates autopsied between January 1, 1984 and June 30, 1993 who were <34 weeks gestation and who lived at least 48 hours; a total of 81 infants.

Results. Three infants had kernicterus resulting in a prevalence rate of 4%. These cases included: 1) a 33-week newborn with nonimmune hydrops and a peak bilirubin of 26 mg/dl; 2) a 25-week newborn with asphyxia, hyaline membrane disease, grade IV intraventricular hemorrhage, necrotizing enterocolitis, meconium peritonitis, sepsis, prolonged acidosis, and a peak bilirubin of 11.3 mg/dl; and 3) a 24-week newborn with asphyxia, hyaline membrane disease, grade III intraventricular hemorrhage, and a peak serum bilirubin of 18.5 mg/dl. Of the remaining 78 infants who did not have kernicterus, peak bilirubin ranged from 3.6 to 22.5 mg/dl and 56% had bilirubin levels greater than that suggested as a criterion for exchange transfusion by NICHD Phototherapy Study guidelines; yet all but three were managed with phototherapy alone.

Conclusions. We conclude that kernicterus is currently an uncommon event in preterm infants, even when bilirubin levels are allowed to rise above those previously thought to place the premature infant at risk.

Submitted on August 2, 1993
Accepted on December 6, 1993




This article has been cited by other articles:


Home page
 Ann Clin BiochemHome page
J. M Kirk
Neonatal jaundice: a critical review of the role and practice of bilirubin analysis
Ann Clin Biochem, September 1, 2008; 45(5): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. J. Maisels
What's in a Name? Physiologic and Pathologic Jaundice: The Conundrum of Defining Normal Bilirubin Levels in the Newborn
Pediatrics, August 1, 2006; 118(2): 805 - 807.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J F Watchko and M J Maisels
Jaundice in low birthweight infants: pathobiology and outcome
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F455 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M J Maisels and J F Watchko
Treatment of jaundice in low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F459 - 463.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. Oh, J. E. Tyson, A. A. Fanaroff, B. R. Vohr, R. Perritt, B. J. Stoll, R. A. Ehrenkranz, W. A. Carlo, S. Shankaran, K. Poole, et al.
Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants
Pediatrics, October 1, 2003; 112(4): 773 - 779.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. B. Amin, C. Ahlfors, M. S. Orlando, L. E. Dalzell, K. S. Merle, and R. Guillet
Bilirubin and Serial Auditory Brainstem Responses in Premature Infants
Pediatrics, April 1, 2001; 107(4): 664 - 670.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. L. Yeo, M. Perlman, Y. Hao, and P. Mullaney
Outcomes of Extremely Premature Infants Related to Their Peak Serum Bilirubin Concentrations and Exposure to Phototherapy
Pediatrics, December 1, 1998; 102(6): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. C. Jackson
Adverse Events Associated With Exchange Transfusion in Healthy and Ill Newborns
Pediatrics, May 1, 1997; 99(5): e7 - e7.
[Abstract] [Full Text] [PDF]